Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with …
Background This multicenter, retrospective study explored the value of oncogene driver
subtype, programmed death‐1 ligand (PD‐L1) status, and smoking status for predicting …
subtype, programmed death‐1 ligand (PD‐L1) status, and smoking status for predicting …
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with …
TL Ng, Y Liu, A Dimou, T Patil, DL Aisner, Z Dong… - Cancer, 2018 - europepmc.org
BACKGROUND: This multicenter, retrospective study explored the value of oncogene driver
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
[PDF][PDF] Predictive Value of Oncogenic Driver Subtype, Programmed Death-1 Ligand (PD-L1) Score, and Smoking Status on the Efficacy of PD-1/PD-L1 Inhibitors in …
MD Tao Jiang, MD Chunxia Su, MD Chunyan Wu… - academia.edu
BACKGROUND: This multicenter, retrospective study explored the value of oncogene driver
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with …
TL Ng, Y Liu, A Dimou, T Patil, DL Aisner, Z Dong… - Cancer, 2019 - pubmed.ncbi.nlm.nih.gov
Background This multicenter, retrospective study explored the value of oncogene driver
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with …
TL Ng, Y Liu, A Dimou, T Patil, DL Aisner, Z Dong… - Cancer, 2018 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> This multicenter, retrospective
study explored the value of oncogene driver subtype, programmed death‐1 ligand (PD‐L1) …
study explored the value of oncogene driver subtype, programmed death‐1 ligand (PD‐L1) …
[PDF][PDF] Predictive Value of Oncogenic Driver Subtype, Programmed Death-1 Ligand (PD-L1) Score, and Smoking Status on the Efficacy of PD-1/PD-L1 Inhibitors in …
MD Tao Jiang, MD Chunxia Su, MD Chunyan Wu… - academia.edu
BACKGROUND: This multicenter, retrospective study explored the value of oncogene driver
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …
subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting …